An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer.
about
The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to BoneWNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.Host and tumor derived MMP13 regulate extravasation and establishment of colorectal metastases in the liver.ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signalingNew strategies for targeting matrix metalloproteinasesMultiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic diseaseCancer-Osteoblast Interaction Reduces Sost Expression in Osteoblasts and Up-Regulates lncRNA MALAT1 in Prostate Cancer.Contributions of the host microenvironment to cancer-induced bone disease.Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression.Clinical implications of compounds designed to inhibit ECM-modifying metalloproteinases.Bone-Seeking Matrix Metalloproteinase-2 Inhibitors Prevent Bone Metastatic Breast Cancer Growth.Atmospheric particulate matter2.5 promotes the migration and invasion of hepatocellular carcinoma cells.STAT3 is involved in esophageal carcinogenesis through regulation of Oct-1.Merging allosteric and active site binding motifs: de novo generation of target selectivity and potency via natural-product-derived fragments.Differential gene regulation and tumor inhibitory activities of alpha-, delta- and gamma-tocopherols in estrogen-mediated mammary carcinogenesis.Breast cancer dissemination promoted by a neuregulin-collagenase 3 signalling node.Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor.Cutting to the Chase: How Matrix Metalloproteinase-2 Activity Controls Breast-Cancer-to-Bone Metastasis.Kinetic characterization of 4,4′-biphenylsulfonamides as selective non-zinc binding MMP inhibitors
P2860
Q30299930-FC0DEB15-53F5-4674-83E6-426440F22F52Q34618790-9A58F3F3-2EAC-458F-BC27-EDECEF1E4480Q34631606-03DEB0D3-5348-4B04-9603-5BF79E9FCCC0Q35154433-A0BEE9B7-03BA-45EE-A5B9-C5B5AF6266CDQ35179502-066B4881-8C74-4886-BED2-9A6685C72283Q35544060-EB75B002-FF96-44DC-994A-D07F1C794181Q36867284-4F38CCA4-8130-4D53-BF91-ED6A2D5457ECQ37200829-365FE903-0183-4009-B174-AE0B5C8956E3Q37663962-CFC58489-6052-4868-9408-85C0ACCF7BCEQ37693503-8F24AD3F-C91C-4CC2-8583-25F37E70DB8DQ38430546-066A1946-8CE3-4D16-AE3A-E788B2BD8B4DQ38722186-4B85D2D2-298A-48B0-9221-0D549E77015EQ38776703-8CC6C6E2-B749-42E5-9E26-EEBC234EEC48Q39240976-9043B8D7-6B61-4308-AEF7-B0D76E679444Q41908389-ABEEE915-058F-495F-A681-78A7052E04FEQ42777954-AB5CA167-9BF7-4DE1-A904-01E07A813D6FQ54246808-E6B1EEFC-824A-4DEA-8FD5-598198BB9D0BQ54997230-A6F4A397-3569-4295-9863-00BC580A567CQ55515529-4B44A0FB-6C93-42AE-964F-49A0BE2C1B97Q58308079-4FC787A6-AC10-4841-AFFB-C804EFDA3FE8
P2860
An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
An MMP13-selective inhibitor d ...... ental models of breast cancer.
@ast
An MMP13-selective inhibitor d ...... ental models of breast cancer.
@en
An MMP13-selective inhibitor d ...... ental models of breast cancer.
@nl
type
label
An MMP13-selective inhibitor d ...... ental models of breast cancer.
@ast
An MMP13-selective inhibitor d ...... ental models of breast cancer.
@en
An MMP13-selective inhibitor d ...... ental models of breast cancer.
@nl
prefLabel
An MMP13-selective inhibitor d ...... ental models of breast cancer.
@ast
An MMP13-selective inhibitor d ...... ental models of breast cancer.
@en
An MMP13-selective inhibitor d ...... ental models of breast cancer.
@nl
P2093
P2860
P1433
P1476
An MMP13-selective inhibitor d ...... ental models of breast cancer.
@en
P2093
Andrea Connor
Conor C Lynch
Dexing Huang
Joel R Hardink
Lawrence A Reiter
Manisha Shah
Mark Waltham
Tony Blick
P2860
P304
P356
10.1371/JOURNAL.PONE.0029615
P407
P577
2012-01-11T00:00:00Z